€22.50
0.71% today
Xetra, Apr 03, 05:35 pm CET
ISIN
DE000A288904
Symbol
COP
Index

CompuGroup Medical Stock price

€22.50
-0.10 0.44% 1M
+8.67 62.69% 6M
+0.74 3.40% YTD
-5.54 19.76% 1Y
-34.90 60.80% 3Y
-40.35 64.20% 5Y
-4.63 17.05% 10Y
Xetra, Closing price Thu, Apr 03 2025
-0.16 0.71%
ISIN
DE000A288904
Symbol
COP
Index
Sector

Key metrics

Market capitalization €1.17b
Enterprise Value €1.95b
P/E (TTM) P/E ratio 46.61
EV/FCF (TTM) EV/FCF 15.84
EV/Sales (TTM) EV/Sales 1.69
P/S ratio (TTM) P/S ratio 1.02
P/B ratio (TTM) P/B ratio 1.85
Dividend yield 0.22%
Last dividend (FY24) €0.05
Revenue growth (TTM) Revenue growth -4.65%
Revenue (TTM) Revenue €1.15b
EBIT (operating result TTM) EBIT €120.14m
Free Cash Flow (TTM) Free Cash Flow €123.09m
Cash position €74.97m
EPS (TTM) EPS €0.49
P/E forward 21.92
P/S forward 1.00
EV/Sales forward 1.67
Show more

Is CompuGroup Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

CompuGroup Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a CompuGroup Medical forecast:

1x Buy
20%
3x Hold
60%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a CompuGroup Medical forecast:

Buy
20%
Hold
60%
Sell
20%

Financial data from CompuGroup Medical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,152 1,152
5% 5%
100%
- Direct Costs 891 891
3% 3%
77%
262 262
24% 24%
23%
- Selling and Administrative Expenses 23 23
68% 68%
2%
- Research and Development Expense - -
-
-
239 239
12% 12%
21%
- Depreciation and Amortization 119 119
8% 8%
10%
EBIT (Operating Income) EBIT 120 120
26% 26%
10%
Net Profit 25 25
67% 67%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about CompuGroup Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CompuGroup Medical Stock News

AD HOC NEWS
17 days ago
Die Baader Bank hat die Einstufung für Compugroup DE000A288904 mit einem Kursziel von 29 Euro auf "Buy" belassen.
AD HOC NEWS
29 days ago
CompuGroup Medical SE & Co. KGaA / DE000A288904
AD HOC NEWS
29 days ago
Der vor einem Rückzug von der Börse stehende Softwareanbieter Compugroup DE000A288904 rechnet nach dem schwachen Vorjahr nun wieder mit etwas Besserung.
More CompuGroup Medical News

Company Profile

CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. The company operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Health Connectivity Services (HCS). The AIS segment focuses on practice management software and electronic medical records for office-based physicians, dentists, medical care centers and physician's networks. The PCS segment focuses on integrated clinical, administrative and financial software applications for retail pharmacies. The HIS segment focuses on clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The HCS segment on customers within the healthcare sector that are outside the healthcare providers. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.

Head office Germany
CEO Daniel Gotthardt
Founded 1987
Website www.cgm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today